东亚药业: 东亚药业关于回购注销部分限制性股票通知债权人的公告

Group 1 - The company has decided to repurchase and cancel 14,000 shares of restricted stock due to one incentive recipient resigning and no longer qualifying for the incentive program [1][2] - Following the repurchase, the total share capital will decrease from 114,739,776 shares to 114,725,776 shares, and the registered capital will correspondingly reduce from 114,739,776 yuan to 114,725,776 yuan [2] - The repurchase and cancellation of restricted stock will involve a reduction in the company's registered capital, and creditors have the right to request debt repayment or guarantees within specified timeframes [2][3] Group 2 - Creditors must submit written requests for debt repayment or guarantees along with relevant documentation to the company [3] - Required materials for debt claims include original and photocopied contracts or agreements proving the existence of the debt relationship, along with identification documents [3] - Claims can be submitted in person or via email, with specific instructions provided for each method [3]